v3.26.3
Earnings Per Share
9 Months Ended
Sep. 30, 2026
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
Shares used in the computation of the Company’s basic and diluted earnings per share are as follows:
(in thousands, except per share data)Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Numerator
Net increase (decrease) in net assets resulting from operations$93,568 $119,685 $266,251 $248,909 
Less: Total distributions declared(87,969)(85,388)(262,652)(249,855)
Total Earnings (loss), net of total distributions5,599 34,297 3,599 (946)
Earnings (loss), net of distributions attributable to common shares5,555 34,042 3,568 (947)
Add: Distributions declared attributable to common shares87,267 84,752 260,320 247,749 
Numerator for basic change in net assets per common share92,822 118,794 263,888 246,802 
Add: Income impact of assumed conversion of 2028 Convertible Notes4,0794,11612,236 9,096
Numerator for diluted change in net assets per common share$96,901 $122,910 $276,124 $255,898 
Denominator
Basic weighted average common shares outstanding185,989180,360184,767175,633
Incremental shares from assumed conversion of 2028 Convertible Notes13,38713,38713,38710,015
Common shares issuable702611683603
Weighted average common shares outstanding assuming dilution200,078194,358198,837186,251
Change in net assets per common share:
Basic$0.50 $0.66 $1.43 $1.41 
Diluted$0.48 $0.63 $1.39 $1.37 
In the table above, unvested share-based payment awards that have non-forfeitable rights to distributions or distribution equivalents are treated as participating securities for calculating earnings per share. Unvested common stock options and restricted stock units are also considered for the purpose of calculating diluted earnings per share.
The issuance of the 2028 Convertible Notes is considered part of the if-converted method for calculation of diluted earnings per share. In applying the if-converted method, conversion is not assumed for purposes of computing diluted earnings per share if the effect would be anti-dilutive. For the three and nine months ended September 30, 2026, there was no anti-dilution when applying the if-converted method for the 2028 Convertible Notes.
The calculation of change in net assets resulting from operations per common share assuming dilution, excludes all anti-dilutive shares. For the three and nine months ended September 30, 2026 and 2025, the number of anti-dilutive shares, as calculated based on the weighted average closing price of the Company’s common stock for the periods, are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
Anti-dilutive Securities2026202520262025
Unvested common stock options451,5271601,217
Unvested restricted stock awards33,068—91,3541,094
As of September 30, 2026 and December 31, 2025, the Company was authorized to issue 300.0 million shares of common stock with a par value of $0.001. Each share of common stock entitles the holder to one vote.